Alana M. Flexman

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 601 citations · Full text

Frailty and postoperative outcomes in patients undergoing surgery for degenerative spine disease

Alana M. Flexman, Raphaële Charest-Morin, Liam Stobart et al. · The Spine Journal · 2016 · 172 citations

Degenerative Spine, Aging, Geriatrics +12

Accuracy and Reliability of Internet Resources for Information on Idiopathic Pulmonary Fibrosis

Jolene H. Fisher, Darragh O’Connor, Alana M. Flexman et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 115 citations

Frailty and sarcopenia do not predict adverse events in an elderly population undergoing non-complex primary elective surgery for degenerative conditions of the lumbar spine

Raphaële Charest-Morin, John Street, Honglin Zhang et al. · The Spine Journal · 2017 · 109 citations

Adverse Events, Lumbar Spine, Degenerative Spine +10

Sarcopenia, but not frailty, predicts early mortality and adverse events after emergent surgery for metastatic disease of the spine

Étienne Bourassa-Moreau, Anne Versteeg, Eryck Moskven et al. · The Spine Journal · 2019 · 101 citations

Adverse Events, Surgical Oncology, Medicine +9